High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.

ABSTRACT:

Background

End of life (EOL) care is associated with greater costs, particularly for acute care services. In patients with inflammatory bowel disease (IBD), EOL costs may be accentuated due to reliance on hospital-based services and expensive diagnostic tests and treatments. We aimed to compare EOL health care use and costs between IBD and non-IBD decedents.

Methods

We conducted a retrospective cohort study of all decedents of Ontario, Canada between 2010 and 2013 using linked health administrative data. IBD (N = 2,214) and non-IBD (N = 262,540) decedents were compared on total direct health care costs in the last year of life and hospitalization time during the last 90 days of life.

Results

During the last 90 days of life, IBD patients spent an average of 16 days in

SUBMITTER: Murthy SK 

PROVIDER: S-EPMC5428925 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature